Direktorat Registrasi ObatExpired

The recorded expiry date has passed. Last reported BPOM status: Valid. A renewal may not yet be reflected in this record.

JARDIANCE

Claim this product
BPOM Number
DKI2124200417B1
Approved
21 November 2024
Expiry
11 September 2026
Form
TABLET SALUT SELAPUT; 25 mg

About This Registration

JARDIANCE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2124200417B1. Its registration status based on the recorded expiry date is Expired, with the licence valid until 11 September 2026. The product is registered to BOEHRINGER INGELHEIM INDONESIA - INDONESIA. BPOM first approved this registration in August 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 7 October 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat
Data Last Updated
7 October 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

EMPAGLIFLOZIN

Market Intelligence

Owner Portfolio
BOEHRINGER INGELHEIM INDONESIA - INDONESIA holds 80 BPOM registrations
Manufacturer Scale
BOEHRINGER INGELHEIM INDONESIA - INDONESIA produces 80 registered products
Registration Age
Registered for 2 years, 2 months
Expiry Status
Expired 58 days ago

FDA Cross-Reference

via openFDA
Generic Name
EMPAGLIFLOZIN
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1